146 related articles for article (PubMed ID: 23454013)
1. Recent developments in targeting protein misfolding diseases.
Denny RA; Gavrin LK; Saiah E
Bioorg Med Chem Lett; 2013 Apr; 23(7):1935-44. PubMed ID: 23454013
[TBL] [Abstract][Full Text] [Related]
2. Small molecules that target protein misfolding.
Gavrin LK; Denny RA; Saiah E
J Med Chem; 2012 Dec; 55(24):10823-43. PubMed ID: 23075044
[TBL] [Abstract][Full Text] [Related]
3. Protein misfolding in disease and small molecule therapies.
Gomes CM
Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
[TBL] [Abstract][Full Text] [Related]
4. Protein Misfolding Diseases and Therapeutic Approaches.
Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes.
Costes S
Curr Opin Pharmacol; 2018 Dec; 43():104-110. PubMed ID: 30245473
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways to polyglutamine aggregation.
Robertson AL; Bottomley SP
Adv Exp Med Biol; 2012; 769():115-24. PubMed ID: 23560307
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological correction of misfolding of ABC proteins.
Rudashevskaya EL; Stockner T; Trauner M; Freissmuth M; Chiba P
Drug Discov Today Technol; 2014 Jun; 12(100):e87-94. PubMed ID: 25027379
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
9. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
[TBL] [Abstract][Full Text] [Related]
10. Small molecule activators of the heat shock response: chemical properties, molecular targets, and therapeutic promise.
West JD; Wang Y; Morano KA
Chem Res Toxicol; 2012 Oct; 25(10):2036-53. PubMed ID: 22799889
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation.
Vendruscolo M
Expert Opin Drug Discov; 2023; 18(8):881-891. PubMed ID: 37276120
[TBL] [Abstract][Full Text] [Related]
12. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
Iram A; Naeem A
Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
[TBL] [Abstract][Full Text] [Related]
14. Chemical kinetics for drug discovery to combat protein aggregation diseases.
Arosio P; Vendruscolo M; Dobson CM; Knowles TP
Trends Pharmacol Sci; 2014 Mar; 35(3):127-35. PubMed ID: 24560688
[TBL] [Abstract][Full Text] [Related]
15. A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.
Baranczak A; Kelly JW
Curr Opin Chem Biol; 2016 Jun; 32():10-21. PubMed ID: 26859714
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose.
Sirangelo I; Irace G
Expert Opin Ther Targets; 2010 Dec; 14(12):1311-21. PubMed ID: 21058920
[TBL] [Abstract][Full Text] [Related]
17. [Selected aspects of amyloidogenesis].
Stepkowski D
Postepy Biochem; 2012; 58(1):110-4. PubMed ID: 23214135
[TBL] [Abstract][Full Text] [Related]
18. Spotlight focuses on protein-misfolding therapies.
Ratner M
Nat Biotechnol; 2009 Oct; 27(10):874. PubMed ID: 19816426
[No Abstract] [Full Text] [Related]
19. Protein-misfolding diseases and the paradigm of proteomics-based therapeutic targets.
Singh OV
Expert Rev Proteomics; 2010 Aug; 7(4):463-4. PubMed ID: 20653501
[No Abstract] [Full Text] [Related]
20. Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.
Ulloa-Aguirre A; Zariñán T; Conn PM
Rev Invest Clin; 2015; 67(1):15-9. PubMed ID: 25857579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
